secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001140361-22-043729
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano completes acquisition of Purigen Biosystems for $32M cash, plus $32M earnout
--------------------------------------------------------------------------------

- Closed acquisition of Purigen Biosystems on Nov 30, 2022; upfront cash consideration ~$32M.
- Up to additional $32M in cash payable upon achievement of certain milestones.
- Purigen survives as a wholly owned subsidiary of Bionano Genomics.
- Consideration subject to customary adjustments for cash, debt, transaction expenses, and net working capital.
- Post-closing purchase price adjustment mechanism with escrow for potential adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036122043729/0001140361-22-043729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036122043729/brhc10044882_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-043729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer